Similar articles

• Immunologic basis of allograft rejection and immunosuppressive agents in intestinal transplantation.

  Vianna R. Vianna R. Minerva Pediatr. 2009 Jun;61(3):293-303. Minerva Pediatr. 2009. PMID: 19461573 Review.
• Selective immunosuppression with FK 506, anti-IL-2R, and anti-ICAM-1 monoclonal antibodies: contrasting effects after liver and small bowel transplantation in rats.

  Otto C, Gasser M, Gassel HJ, Steger U, Timmermann W, Meyer D, Ulrichs K, Thiede A. Otto C, et al. Transplant Proc. 1998 Aug;30(5):2161-2. doi: 10.1016/s0041-1345(98)00573-9. Transplant Proc. 1998. PMID: 9723426 No abstract available.
• Clinical aspects of small-bowel transplantation.

  Veenendaal RA, Ringers J, Baranski A, van Hoek B, Lamers CB. Veenendaal RA, et al. Scand J Gastroenterol Suppl. 2000;(232):65-8. Scand J Gastroenterol Suppl. 2000. PMID: 11232495 Review.
• Rejection and survival after total orthotopic liver-small bowel allotransplantation in pigs immunosuppressed with FK 506.

  Velio P, Tarantino C, Bertoglio C, Guffanti E, Bardella MT, Biffi R, Andreoni B, Rossi G, Gatti S, Piazzini A, Fassati LR, Galmarini D. Velio P, et al. Transplant Proc. 1996 Oct;28(5):2529-30. Transplant Proc. 1996. PMID: 8907936 No abstract available.
• Evolutionary experience with immunosuppression in pediatric intestinal transplantation.

  Bond GJ, Mazariegos GV, Sindhi R, Abu-Elmagd KM, Reyes J. Bond GJ, et al. J Pediatr Surg. 2005 Jan;40(1):274-9; discussion 279-80. doi: 10.1016/j.jpedsurg.2004.09.020. J Pediatr Surg. 2005. PMID: 15868597